Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rodenhuis

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|April 3, 2003
Marker genes for circulating tumour cells predict survival in metastasized breast cancer patientsB Weigelt, A J Bosma, A A M Hart, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancyA M Westermann, R Dubbelman, J P Baars, et al.
Anti-Cancer Drugs|January 12, 2000
Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimensJ Y Blay, I Judson, S Rodenhuis, et al.
Cancer Journal (Sudbury, Mass.)|May 10, 2000
High-dose chemotherapy with peripheral blood progenitor cell transplantation in the adjuvant treatment of breast cancerS Rodenhuis, A D Huitema, F S van Dam, et al.
Bone Marrow Transplantation|August 18, 2001
Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancerJ G Schrama, J W Baars, M J Holtkamp, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
The use of the Calvert formula to determine the optimal carboplatin dosageL J van Warmerdam, S Rodenhuis, W W ten Bokkel Huinink, et al.
British Journal of Clinical Pharmacology|February 13, 2001
Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapyA D Huitema, R A Mathôt, M M Tibben, et al.
Thorax|May 1, 1993
Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activatorS Rodenhuis, L G van't Hek, L T Vlasveld, et al.
Blood|June 1, 1986
Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhoodS Rodenhuis, J L Bos, R M Slater, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Unchanged pharmacokinetics of etoposide given by intra-arterial hepatic infusion as compared with i.v. infusionO van Tellingen, M T Kuck, L T Vlasveld, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|April 3, 2003
Marker genes for circulating tumour cells predict survival in metastasized breast cancer patientsB Weigelt, A J Bosma, A A M Hart, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancyA M Westermann, R Dubbelman, J P Baars, et al.
Anti-Cancer Drugs|January 12, 2000
Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimensJ Y Blay, I Judson, S Rodenhuis, et al.
Cancer Journal (Sudbury, Mass.)|May 10, 2000
High-dose chemotherapy with peripheral blood progenitor cell transplantation in the adjuvant treatment of breast cancerS Rodenhuis, A D Huitema, F S van Dam, et al.
Bone Marrow Transplantation|August 18, 2001
Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancerJ G Schrama, J W Baars, M J Holtkamp, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
The use of the Calvert formula to determine the optimal carboplatin dosageL J van Warmerdam, S Rodenhuis, W W ten Bokkel Huinink, et al.
British Journal of Clinical Pharmacology|February 13, 2001
Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapyA D Huitema, R A Mathôt, M M Tibben, et al.
Thorax|May 1, 1993
Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activatorS Rodenhuis, L G van't Hek, L T Vlasveld, et al.
Blood|June 1, 1986
Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhoodS Rodenhuis, J L Bos, R M Slater, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Unchanged pharmacokinetics of etoposide given by intra-arterial hepatic infusion as compared with i.v. infusionO van Tellingen, M T Kuck, L T Vlasveld, et al.
Pageof 15